Skip to content

HROW

Harrow Health, Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US

$38.54
+0.73%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$450.0K
Net value (3m)
+15.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 17, 2026Shojaei Amir · officer: CHIEF SCIENTIFIC OFFICERSale11,250$40
Aug 17, 2026Shojaei Amir · officer: CHIEF SCIENTIFIC OFFICERM-Exempt11,250$36
Jun 22, 2026Sternberg Perry J. · directorA-Award5,248$0.00
Jun 22, 2026Graves Adrienne L · directorA-Award5,248$0.00
Jun 22, 2026SILVERNAIL LAUREN P · directorA-Award5,248$0.00
May 19, 2026Graves Adrienne L · directorPurchase1,000$31
May 19, 2026SILVERNAIL LAUREN P · directorPurchase1,000$31
May 18, 2026Shojaei Amir · officer: CHIEF SCIENTIFIC OFFICERA-Award10,000$0.00
May 15, 2026BOLL ANDREW R. · officer: PRESIDENT AND CFOPurchase3,500$30
May 15, 2026BAUM MARK L · director, officer: CHIEF EXECUTIVE OFFICERPurchase10,000$30
Mar 5, 2026Opaleye Management Inc. · 10 percent ownerSale4,263$40
Mar 5, 2026Opaleye Management Inc. · 10 percent ownerSale134,000$40
Mar 5, 2026Opaleye Management Inc. · 10 percent ownerSale59,000$39
Mar 5, 2026Opaleye Management Inc. · 10 percent ownerSale1,309$39
Feb 2, 2026Sullivan Patrick William · officer: CHIEF COMMERCIAL OFFICERA-Award15,000$0.00
Feb 2, 2026Sullivan Patrick William · officer: CHIEF COMMERCIAL OFFICERA-Award25,000$0.00
Jan 8, 2026Opaleye Management Inc. · 10 percent ownerSale20,000$53
Dec 16, 2025BAUM MARK L · director, officer: CHIEF EXECUTIVE OFFICERM-Exempt180,000$3.95
Dec 16, 2025BOLL ANDREW R. · officer: PRESIDENT AND CFOF-InKind26,665$47
Dec 16, 2025BOLL ANDREW R. · officer: PRESIDENT AND CFOM-Exempt60,000$3.95
Dec 16, 2025BAUM MARK L · director, officer: CHIEF EXECUTIVE OFFICERF-InKind79,994$47
Sep 9, 2025Pollard Randall E. · officer: CHIEF ACCOUNTING OFFICERA-Award30,000$39
Jul 23, 2025BAUM MARK L · director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICERM-Exempt600,000$7.87
Jul 23, 2025BAUM MARK L · director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICERF-InKind313,338$37
Jul 1, 2025BAUM MARK L · director, officer: CHIEF EXECUTIVE OFFICERA-Award889,500$0.00
Jul 1, 2025BOLL ANDREW R. · officer: CHIEF FINANCIAL OFFICERA-Award405,750$0.00
Jun 24, 2025Graves Adrienne L · directorA-Award7,339$0.00
Jun 24, 2025Sternberg Perry J. · directorA-Award7,339$0.00
Jun 24, 2025SILVERNAIL LAUREN P · directorA-Award7,339$0.00
Jun 11, 2025Opaleye Management Inc. · 10 percent ownerSale15,000$31
Institutional positioning

13F filings over the trailing two quarters

New 86Increased 145Reduced 147Sold out 36
FilerActionSharesFiled
OPALEYE MANAGEMENT INC.Reduced2,832,230May 15, 2026
BlackRock, Inc.Increased2,740,117Aug 7, 2026
BLACKROCK, INC.Reduced2,552,759May 13, 2026
Opaleye Management Inc.Reduced2,400,000Aug 14, 2026
Private Capital Management, LLCIncreased1,616,270Aug 14, 2026
PRIVATE CAPITAL MANAGEMENT, LLCReduced1,603,000May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased1,471,082May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased1,417,212Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position1,403,056May 15, 2026
LUXOR CAPITAL GROUP, LPIncreased1,119,400May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPReduced1,117,316Aug 14, 2026
CITADEL ADVISORS LLCIncreased984,274Sep 2, 2026
Deep Track Capital, LPNew Position969,000Aug 14, 2026
STATE STREET CORPIncreased939,888Aug 7, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased905,560Aug 12, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 17, 2026